Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.
about
Stress-Related Immune Markers in Depression: Implications for TreatmentAdvances in Medications and Tailoring Treatment for Alcohol Use DisorderFrom pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentPharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responseAssociation study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant responseEthnopsychopharmacologyLoudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depressionSequence variation and linkage disequilibrium in the GABA transporter-1 gene (SLC6A1) in five populations: implications for pharmacogenetic research.Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.Antidepressant response and the serotonin transporter gene-linked polymorphic regionRealities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.Pharmacogenetics of antidepressant response.Convergent evidence from mouse and human studies suggests the involvement of zinc finger protein 326 gene in antidepressant treatment response.Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy.Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Neuroticism mediates the association of the serotonin transporter gene with lifetime major depression.Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.The norepinephrine transporter gene is associated with the retardation symptoms of major depressive disorder in the Han Chinese population.Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects.Pharmacogenetics of monoamine transporters.The promise and reality of pharmacogenetics in psychiatryPharmacogenomic strategy for individualizing antidepressant therapy.Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.Pharmacogenomics of antidepressant treatment effectsBrain SERT Expression of Male Rats Is Reduced by Aging and Increased by Testosterone RestitutionInfluence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.The pharmacogenomics of selective serotonin reuptake inhibitors.Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and response.The emerging role of pharmacogenetics: implications for clinical psychiatry.Serotonin transporters: implications for antidepressant drug development.Pharmacogenomics and antidepressant drugs.Contribution of allelic variations in transporters to the phenotype of drug response.Serotonergic vulnerability and depression: assumptions, experimental evidence and implications.Candidate genes for antidepressant response to selective serotonin reuptake inhibitorsPharmacogenetic studies in depression: a proposal for methodologic guidelines.Eating disorders: an overview of treatment responses and the potential impact of vulnerability genes and endophenotypes.Association study of serotonin transporter gene polymorphisms with obstructive sleep apnea syndrome in Chinese Han population.Development × environment interactions control tph2 mRNA expression.The serotonin transporter gene and effectiveness of SSRIs.
P2860
Q26771607-4BEEBC50-6D09-415E-841B-5E7243604DD1Q26799814-77673EC6-911B-49A2-87FD-16943AF8100AQ27015830-51602CE4-B125-494A-BD31-2439D4FB9AA2Q28252209-96E8D4B9-3827-40AE-972C-ED79EF3E3EDCQ28256653-9AD7B408-1F0B-4D1B-B228-F9A2D257E81AQ28301029-FB87FFAA-CE62-4281-9BEC-FC2CE0E10A51Q30499812-F6E76B9B-85FB-4EE3-BF8A-A6F10C83CBA6Q33302969-33042636-3482-4F2E-9B5A-194B1CBD730FQ33710367-1ADB5C5F-A405-4384-80E5-BE40543A5854Q34088515-523BCA0B-D230-4345-A544-CA11B53D9111Q34131354-FBBA9D4F-6A79-4C9D-8BF9-CD4DBDA33BBFQ34155796-440EB826-D728-4F80-859D-E45C0FD2944FQ34292369-922A430F-5413-4596-A41E-F1D1B7C79B6BQ34316695-FD6B0B37-CA89-4C93-8571-3F56FD8E7470Q34424865-5B4B70D2-91FE-406A-AE90-8BEDA5FA3093Q34471654-29EF94FB-52C1-4408-9010-4864CF4B3DCBQ34552006-D540CAD6-AD4D-47ED-A5A7-2504A42B96B9Q34871885-994599F7-0CED-4BB0-B3A8-B2FD15BC4F6FQ34984385-8A845548-5E3F-4F41-925D-430166670271Q35012645-499BCD06-9707-4448-A479-27412C26B1C9Q35207551-2945E238-2562-41CB-BECE-CBDE261C994FQ35226451-6CBA2E7B-69CA-48A4-AA67-C0F0DF8E2F66Q35237038-A9477D46-8D3C-4661-86FC-93235BF83357Q35237042-BACC388C-E424-49DF-8F05-AAB16ED51427Q35237236-9304B547-EED9-453F-AE62-0C9C92864277Q35623234-3500183A-A450-4411-8422-761F18C508C2Q35705858-4C905B8D-EFC9-48AA-AD1D-5B44E66F4826Q35757723-117232DD-B21C-4821-A911-E14203DCE15EQ35814369-D4480768-3823-495B-8753-7E3D9452C682Q35837661-1D432EBB-F980-40E9-9B2C-CD45E29AEA49Q36341615-3C41E5FF-8E86-4044-9474-8D16D6C499DFQ36438205-F680EFD1-2C3D-40FA-9B1C-9B04C4B7DE0CQ36511673-615E3B4E-A46C-4112-AC41-8A98EA390266Q36679249-DC082752-1EC4-40F0-8997-DC4156F61CA3Q36718053-B905FB4C-7F38-41FD-A4E0-40B5EFFB8138Q36904466-A1315F4D-73B1-4D2D-A891-9EADC9297F6AQ36916902-3CB83CBA-367E-41CA-A1F0-35B3801279FCQ36965936-F9D1B72E-F9FF-418F-92C7-0D3D3B198838Q36987296-A394C007-1B63-4FBD-9BCD-08BDB167FDF9Q37035245-9E6E6119-5388-47AB-A7EB-8784F393BFC2
P2860
Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Association study of the serot ...... in major depressive disorders.
@en
Association study of the serot ...... in major depressive disorders.
@nl
type
label
Association study of the serot ...... in major depressive disorders.
@en
Association study of the serot ...... in major depressive disorders.
@nl
prefLabel
Association study of the serot ...... in major depressive disorders.
@en
Association study of the serot ...... in major depressive disorders.
@nl
P2093
P2860
P356
P1433
P1476
Association study of the serot ...... in major depressive disorders.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.MP.4001141
P407
P577
2002-01-01T00:00:00Z